ODG
GILD icon

O'Dell Group’s Gilead Sciences GILD Stock Holding History

O'Dell Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-834
Closed -$67.5K – 243
2023
Q4 		$67.5K Buy
+834
New +$64.9K 0.02% 176
2023
Q3 		– Sell
-829
Closed -$63.9K – 229
2023
Q2 		$63.9K Buy
+829
New +$66.1K 0.02% 170
2022
Q4 		– Sell
-823
Closed -$51K – 203
2022
Q3 		$51K Buy
823
+3
+0.4% +$189 0.02% 144
2022
Q2 		$51K Buy
820
+3
+0.4% +$186 0.02% 149
2022
Q1 		$49K Buy
817
+3
+0.4% +$192 0.01% 173
2021
Q4 		$59K Buy
814
+2
+0.2% +$138 0.02% 148
2021
Q3 		$57K Buy
+812
New +$57K 0.02% 154

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

O'Dell Group's GILD Position: Q1 2024 in Review

O'Dell Group sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 834 shares — an estimated $67.5K sold.

O'Dell Group first reported a position in GILD in Q3 2021 and held it in 7 quarters. The position peaked at $67.5K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • O'Dell Group reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 834 Gilead Sciences shares in Q1 2024, an estimated $67.5K.
  • O'Dell Group first reported a position in Gilead Sciences in Q3 2021 and held it in 7 quarters.
  • O'Dell Group's Gilead Sciences position peaked at $67.5K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.